FDA Class II · Drug · July 1, 2026
DULOXETINE D/R recall — Direct Rx
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Official ID D-0617-2026 · Official record ↗
1 recent recall on record for Direct Rx in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Official ID D-0617-2026 · Official record ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.